{
"@context": "https://schema.org",
"@type": "Article",
"headline": "FDA’s Proposed Rule on LDT Regulation and the Debate over Agency Deference",
"url": "https://www.lexblog.com/2023/10/18/fdas-proposed-rule-on-ldt-regulation-and-the-debate-over-agency-deference/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-YJRH7KWH",
"url": "https://www.lexblog.com/lib/YJRH7KWH/"
},
"datePublished": "2023-10-18T17:15:51-04:00",
"dateModified": "2023-10-19T09:04:59-04:00",
"author": {
"@type": "Person",
"name": "Dominick DiSabatino, Audrey Mercer"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Sheppard, Mullin, Richter & Hampton LLP"
},
"organizationScope": "at-publication",
"about": "Administrative and Regulatory · Health Care and Life Sciences",
"sourceUrl": "https://www.fdalawblog.com/?p=2116",
"sourceStability": "may-move"
}